News & Updates

Show Multimedia Only
Diabetes ups mortality risk in TB patients
Diabetes ups mortality risk in TB patients
25 Jun 2024 byStephen Padilla

People diagnosed with tuberculosis (TB) face a worse prognosis if they also have untreated or complicated diabetes mellitus (DM), according to a study.

Diabetes ups mortality risk in TB patients
25 Jun 2024
Longest ever PFS in advanced NSCLC CROWNs lorlatinib’s 5-year data
Longest ever PFS in advanced NSCLC CROWNs lorlatinib’s 5-year data
25 Jun 2024 byNatalia Reoutova

After 5 years of follow-up, median progression-free survival (PFS) has still not been reached in patients with advanced non-small-cell lung cancer (NSCLC) treated with lorlatinib in the phase III CROWN study, corresponding to the longest PFS ever reported with any single-agent molecular targeted treatment in advanced NSCLC and across all metastatic solid tumours.

Longest ever PFS in advanced NSCLC CROWNs lorlatinib’s 5-year data
25 Jun 2024